Pfizer/BioNTech vaccine announcement is cause for cautious celebration

934143

Sumary of Pfizer/BioNTech vaccine announcement is cause for cautious celebration:

  • It is not yet the end of the pandemic, but the announcement by Pfizer/BioNTech that their vaccine has been 90% successful in the vital large-scale trials has got even the soberest of scientists excited..
  • The two companies – a tiny German biotech with the big idea and the giant pharma company Pfizer with the means to develop it – have not yet published their detailed data, so it is all on trust..
  • Covid-19 vaccine candidate is 90% effective, says Pfizer Most of us will not be vaccinated by Christmas, but it is possible the first shots will be given before the end of the year..
  • Europe, the US and the UK have all pre-bought supplies of the Pfizer/BioNTech vaccine – there will be 200m doses going to the EU, 100m to the US and 40m to the UK..
  • Remarkably, the Pfizer/BioNTech vaccine could be the first vaccine to be approved using the new technology called mRNA, which delivers the genetic code of the virus into the body, rather than any part of the virus itself…

Want to know more click here go to health news source.

From -

Close

Languages